|
Jeannetta
G. Sanders, FACHE, president and CEO, Horizon Health Group, Rockville,
Maryland
ORGANIZATIONAL
INFORMATION
Two organizations
are the subject of this article: a community general hospital and a
four-person private practice surgery group working at the hospital.
The hospital, a private not-for-profit institution established in 1921,
is a 300-bed Joint Commission-accredited hospital. It is governed by
a board of directors composed of both community laypersons and physicians.
The surgical group comprises three general and vascular surgeons and
one general surgeon. Established in 1974, the group performs 80 percent
of the vascular surgery in its market and a large percentage of the
general surgery. It is owned by two senior partners and governed by
a board of directors composed of the two owners and the CEO. Both the
hospital and the physician group are in a suburban location with a population
of approximately 400,000.
BRIEF
STATEMENT OF THE PROBLEM
Minimally
invasive and endovascular surgical techniques have been developed to
diagnose and treat vascular disease. Several specialties are involved
in using these techniques. Implementation of an endovascular program
within the hospital required new alliances among executives, radiologists,
cardiologists, and the vascular surgeons. An integrated program was
necessary to maximize the clinical and financial success for all parties.
DESCRIPTION
OF THE PROBLEM
Endovascular
Treatment
To better understand this problem a brief background of the evolution
of endovascular techniques is helpful. Endovascular refers to the diagnosis
and treatment of vascular disease via percutaneous or minimally invasive
access to blood vessels. This innovation obviates the need for open
surgery and is similar in impact to the laparoscopic treatment of abdominal
disease, in which very small incisions are made into the patient's abdomen
through which trocars or ports are placed for the removal of a diseased
organ.
The skills
necessary for a physician to perform endovascular procedures incorporate
vascular surgical techniques and the use of guidewires, balloons, and
catheters inserted through a puncture wound to reach the diseased vessel,
and all procedures are done under x-ray guidance. Traditionally, percutaneous
procedures in this community were performed in radiology suites by interventional
radiologists, in cardiac catheterization laboratories by cardiologists,
or in the operating room by vascular surgeons.
Cardiologists
started using the techniques they learned in cardiac catheterization
laboratories to treat peripheral vascular lesions. Radiologists developed
newer methods of treating vascular disease as more sophisticated balloons
and stents were developed. The vascular surgeons saw their patient volume
diminish and learned endovascular methods, extended endovascular techniques
to open surgical procedures, and wanted procedure time available in
the angiography suites.
Turf battles
and competition made these changes a significant problem for hospital
executives and the physicians involved. These problems have been experienced
nationally and are often addressed in physicians' specialty-specific
meetings. Ideally the three specialties would develop uniform criteria
for procedure performance and follow through using similar equipment
and supplies in the least-expensive site.
Problems
Within the Hospital
The hospital's
program development was complicated by the difficulty of developing
credentialing criteria among disparate groups of specialists. As endovascular
techniques evolved, there was an overlap in the clinical capabilities
of the different specialties to perform procedures not traditionally
under their domain. Furthermore, the hospital CEO recognized that the
political problems that endovascular programs have introduced nationally
now existed in his hospital.
General
and vascular surgeons and invasive cardiologists perform endovascular
procedures in the normal course of their clinical care of patients.
For general and vascular surgeons this includes the insertion of inferior
vena cava filters, dialysis grafts, and other clinical interventions.
Invasive cardiologists perform cardiac angioplasty and cardiac imaging
via the use of guidewires and other radiologic techniques. These endovascular
procedures involve the use of radiologic imaging equipment, which can
prompt clinical competition.
The hospital
had recruited a cardiologist to develop a cardiac catheterization laboratory
in spite of an absence of cardiac surgery within the hospital. His clinical
interest went beyond cardiac intervention. Although he had not previously
performed peripheral vascular interventions, he planned to do so.
The vascular
surgery group had been affiliated with the hospital for 25 years. Its
accomplishments included establishment of a breast diagnostic facility,
a freestanding outpatient laboratory, and a vascular testing facility.
Additionally, the senior surgical partner had first introduced laparoscopic
surgical techniques into the community at this hospital. Most significantly,
the senior surgeon had spent extensive time studying and incorporating
endovascular methods into his set of surgical skills.
The radiologists
were concerned that a multispecialty endovascular program could usurp
their usual clinical domain. The hospital CEO also expressed concern
that opening access to endovascular procedures for other specialists
could result in a loss of the cardiac catheterization business.
Endovascular
procedures within this community hospital were performed in a fragmented,
specialty-specific manner. However, the hospital recognized the emerging
importance of an endovascular program. In 1997, the senior partner of
the surgical group approached the hospital CEO with a proposal for the
development of an integrated approach to the performance of endovascular
procedures. His plan outlined criteria for the radiologists, cardiologists,
and vascular surgeons to perform these endovascular procedures in all
appropriate procedure suites. The CEO was reluctant to accept this challenge
for the political reasons outlined above and tabled the program's development
at that time.
Need
for Compromise
1998 was an appropriate time to reintroduce this concept based on the
clinical acceptance and imminent Food and Drug Administration (FDA)
approval of endovascular devices to repair abdominal aortic aneurysms.
As CEO of the general and vascular group, I was responsible for working
with the senior partner of our organization and the CEO of the hospital
to develop this endovascular program.
The treatment
of abdominal aortic aneurysms has not changed for 50 years. The repair
involves major surgery, which results in a 97 percent success rate when
performed electively. It is, however, a traumatic surgery that entails
significant hospital resources and lengthy patient recuperation.
In 1991,
Dr. Juan Parodi, an Argentinean, introduced an endovascular graft that
was inserted through a small incision in the groin to repair abdominal
aortic aneurysms. American corporations began the aggressive development
and FDA-approved clinical trials of endovascular abdominal aortic aneurysm
repair devices. Further development produced clinical outcomes comparable
to the open method but with drastically reduced hospital length of stay,
cost, and patient recuperation time.
To be prepared
for endovascular techniques such as abdominal aortic aneurysm repair,
the hospital clearly had to develop an endovascular program or face
clinical obsolescence and a decline in revenue. As in the 1980s with
laparoscopy, endovascular abdominal aortic aneurysm repair has a great
potential impact on patient treatment and subsequent hospital and physician
reimbursement.
ADMINISTRATIVE
DECISIONS
As CEO
of the surgical group, I was responsible for ensuring the financial
success of the organization. I was confident that we would be clinically
and financially best served if we could implement an endovascular program.
As a former hospital executive, I understood the multifaceted nature
of the hospital CEO's political and financial concerns. I met with the
board of directors of my organization and recommended that the hospital
CEO be approached again with a concrete proposal for development of
an endovascular program. The proposal included the following components:
- The
approach would limit the hospital CEO's political exposure.
- The
senior vascular surgeon would present the plan to the hospital CEO.
This would emphasize the clinical nature of the program and was in
harmony with the leadership role this physician plays in the medical
community.
- The
program included creation of an endovascular committee, development
of hospital credentialing criteria for performance of endovascular
procedures in all appropriate procedure suites throughout the hospital,
and establishment of an abdominal aortic aneurysm repair team.
- The
key feature of the proposal was the ability to treat abdominal aortic
aneurysms with an endovascular approach within the hospital.
- The
senior surgeon worked with the interventional radiologists to learn
to perform arteriograms and other guidewire procedures in both the
radiology and operating room suites. He accomplished this by inviting
the chief interventional radiologist to be a participant in the design
of an abdominal aortic aneurysm repair program. The surgeon demonstrated
to the radiologist that the imminent FDA approval of endovascular
abdominal aortic aneurysm repair devices would necessitate a collaborative
approach to avoid losing market share to other hospitals that had
endovascular abdominal aortic aneurysm repair capabilities.
- The
senior vascular surgeon attended the clinical training programs he
knew would be necessary to allow the hospital program to be functioning
on final FDA approval of the grafts.
- An analysis
of the efforts of the four other local hospitals relative to endovascular
program development was conducted; little organized effort to establish
an endovascular program was occurring. This presented a window of
opportunity to develop a program in conjunction with the community
general hospital.
RESULTS
The senior
vascular surgeon met with the hospital CEO in early 1999. He presented
the program as outlined above, including his collaborative work with
the interventional radiologist. The data from the local hospitals were
presented, along with the FDA projection of imminent approval of abdominal
aortic aneurysm grafts. A tentative outline of the goals of the proposed
endovascular committee as well as members of the aortic aneurysm team
were reviewed.
The CEO
now viewed this program as advantageous. He agreed to commit capital
resources to the endovascular program and make it one of the hospital's
strategic initiatives. Credentialing criteria were drafted and approved
by the hospital's board of directors. The hospital's team of operating
room nurses, x-ray technicians, and postoperative nurses was trained
by the vascular surgeon.
In September
1999, the FDA approved two devices for clinical use for abdominal aortic
aneurysm repair. The senior surgeon trained the interventional radiologists
in the insertion of the abdominal aortic aneurysm graft. This training
took place in the operating room suite and introduced "nonsurgeons"
into the vascular surgery arena at the hospital for the first time.
The first
case was performed in March 2000. The patient was operated on with epidural
anesthesia and was discharged in 48 hours, a significant reduction from
the standard five to seven days required with open repair. This remarkable
accomplishment helped rally the three clinical groups to work together.
The hospital's endovascular committee now meets monthly and reviews
cases performed in all areas of the hospital and by all credentialed
physicians (vascular surgeons, cardiologists, and radiologists).
In 2001,
the American Medical Association published CPT codes specifically describing
endovascular aortic aneurysm repair, and the Health Care Financing Administration
recognized these codes for Medicare reimbursement.
The hospital's
surgical team is viewed as very accomplished by device manufacturers.
The senior surgeon has invited representatives from all developers to
attend cases when patients agreed. This has promoted the reputation
of the surgical group as well as the hospital as a training organization;
the physician group has been targeted by one manufacturer to be the
site for national training. The FDA invited the vascular surgeon to
speak to its team on abdominal aortic aneurysm grafts. This invitation
was unusual, as physician presenters are typically representatives of
universities rather than community hospitals and private practice groups.
The surgeon
is a guest speaker on endovascular surgery for both lay and professional
groups. He was featured in a local newspaper and in the newspaper's
online program on vascular disease. The online discussion was the impetus
for a patient to travel 900 miles for treatment. This in turn led to
further press coverage that positively presented the hospital as well
as the surgical group.
The organization
has evaluated 75 patients for endovascular repair of their aneurysms;
26 procedures have been performed, converting three to open procedures,
with no deaths and all positive clinical outcomes. Patients are now
discharged 24 hours following repair, with cases typically performed
under local anesthesia and intravenous sedation.
The hospital
CEO informed me that reimbursement for endovascular abdominal aortic
aneurysm repair has been positive, largely because of the decreased
length of stay. The cost of the endovascular graft is approximately
$10,000. It is anticipated that over time this will decline, thus providing
further financial benefit to the hospital as well as payers and patients.
Because
of the cooperation of the surgeons, radiologists, and hospital, cooperative
marketing has occurred. The hospital CEO and I arranged two highly successful
seminars on abdominal aortic aneurysms and vascular disease for the
community. Establishment of the endovascular surgery program required
years of clinical and financial planning, but the organization has significantly
benefited from the program. Although the other four area hospitals are
in various stages of program development, this hospital is the leader
and plans to remain in that position.
Sources
The author
utilized knowledge and experience in clinical program development for
this case presentation. The articles listed in the bibliography were
also sources of information specific to endovascular program development
and implementation.
Bibliography
Levin,
D., et al. 1992. "Training Standards for Physicians Performing
Peripheral Angioplasty and Other Percutaneous Peripheral Vascular Interventions."
Circulation 86: 1348-50.
Sacks,
D. 1999. "Quality First: Credentialing for Peripheral Vascular
Procedures." Advance for Administrators in Radiology and Radiation
Oncology (February): 44-50.
Silva,
M., et al. 1996. "A Program of Operative Angioplasty: Endovascular
Intervention and the Vascular Surgeon." Journal of Vascular Surgery
24: 948-49.
White,
R., et al. 1999. "Endovascular Interventions Training and Credentialing
for Vascular Surgeons." Journal of Vascular Surgery 29: 27-40.
|